title: [Cardiac involvement in polymyositis].
abstract: Cardiovascular involvement in polymyositis constitutes a major cause of death. However, the cardiac location is rarely symptomatic and does not usually represent the principle clinical feature at the time of the initial presentation. We present here an unusual case of polymyositis with severe and polymorph cardiac disturbances that predominant the muscular signs.
authors: Service de cardiologie, hôpital Farhat Hached, rue Ibn El Jazzar, 4000 Sousse, Tunisie. meriembenromdhane15@yahoo.com
authors: M B
authors: MB
authors: Romdhane
authors: A
authors: A
authors: Mahdhaoui
authors: M B
authors: MB
authors: Khelifa
authors: A
authors: A
authors: Lagren
authors: S E
authors: SE
authors: Hajri
authors: H
authors: H
authors: Bouraoui
authors: B
authors: B
authors: Trimeche
authors: N
authors: N
authors: Ghannouchi
authors: G
authors: G
authors: Jeridi
authors: F
authors: F
authors: Bahri
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000627:therapeutic use; D054537:Atrioventricular Block / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D002037:Bundle-Branch Block / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D006332:Cardiomegaly / Q000150:complications / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004417:Dyspnea / Q000209:etiology; D004562:Electrocardiography; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007297:Inpatients; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D017285:Polymyositis / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D004232:Diuretics; D007166:Immunosuppressive Agents; D008727:Methotrexate